The European Medicines Agency (EMA) on Monday approved a Pfizer/BioNTech Covid vaccine targeting the Omicron BA.4 and BA.5 sublines;
that evade the immune system more easily than earlier strains.
To discover
OUR FILE - Elizabeth II, a rock and a symbol for England
"
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended authorizing an adapted bivalent vaccine targeting Omicron BA.4 and BA.5 subvariants in addition to the original strain of SARS-CoV- 2
,” the EMA said in a statement.
